SFRP2 Overexpression Induces an Osteoblast-like Phenotype in Prostate Cancer Cells

Prostate cancer bone metastasis is still one of the most fatal cancer diagnoses for men. Survival of the circulating prostate tumor cells and their adaptation strategy to survive in the bone niche is the key point to determining metastasis in early cancer stages. The promoter of <i>SFRP2</i...

Full description

Bibliographic Details
Main Authors: Elif Akova Ölken, Attila Aszodi, Hanna Taipaleenmäki, Hiroaki Saito, Veronika Schönitzer, Michael Chaloupka, Maria Apfelbeck, Wolfgang Böcker, Maximilian Michael Saller
Format: Article
Language:English
Published: MDPI AG 2022-12-01
Series:Cells
Subjects:
Online Access:https://www.mdpi.com/2073-4409/11/24/4081
_version_ 1797460976798269440
author Elif Akova Ölken
Attila Aszodi
Hanna Taipaleenmäki
Hiroaki Saito
Veronika Schönitzer
Michael Chaloupka
Maria Apfelbeck
Wolfgang Böcker
Maximilian Michael Saller
author_facet Elif Akova Ölken
Attila Aszodi
Hanna Taipaleenmäki
Hiroaki Saito
Veronika Schönitzer
Michael Chaloupka
Maria Apfelbeck
Wolfgang Böcker
Maximilian Michael Saller
author_sort Elif Akova Ölken
collection DOAJ
description Prostate cancer bone metastasis is still one of the most fatal cancer diagnoses for men. Survival of the circulating prostate tumor cells and their adaptation strategy to survive in the bone niche is the key point to determining metastasis in early cancer stages. The promoter of <i>SFRP2</i> gene, encoding a WNT signaling modulator, is hypermethylated in many cancer types including prostate cancer. Moreover, SFRP2 can positively regulate osteogenic differentiation in vitro and in vivo. Here, we showed SFRP2 overexpression in the prostate cancer cell line PC3 induces an epithelial mesenchymal transition (EMT), increases the attachment, and modifies the transcriptome towards an osteoblast-like phenotype (osteomimicry) in a collagen 1-dependent manner. Our data reflect a novel molecular mechanism concerning how metastasizing prostate cancer cells might increase their chance to survive within bone tissue.
first_indexed 2024-03-09T17:12:48Z
format Article
id doaj.art-e19c6cd467164e86b2736e2ce4c19eb7
institution Directory Open Access Journal
issn 2073-4409
language English
last_indexed 2024-03-09T17:12:48Z
publishDate 2022-12-01
publisher MDPI AG
record_format Article
series Cells
spelling doaj.art-e19c6cd467164e86b2736e2ce4c19eb72023-11-24T13:55:28ZengMDPI AGCells2073-44092022-12-011124408110.3390/cells11244081SFRP2 Overexpression Induces an Osteoblast-like Phenotype in Prostate Cancer CellsElif Akova Ölken0Attila Aszodi1Hanna Taipaleenmäki2Hiroaki Saito3Veronika Schönitzer4Michael Chaloupka5Maria Apfelbeck6Wolfgang Böcker7Maximilian Michael Saller8Department of Orthopaedics and Trauma Surgery, Musculoskeletal University Center Munich (MUM), Ludwig-Maximilians-University (LMU) Hospital, Fraunhoferstraße 20, 82152 Planegg-Martinsried, GermanyDepartment of Orthopaedics and Trauma Surgery, Musculoskeletal University Center Munich (MUM), Ludwig-Maximilians-University (LMU) Hospital, Fraunhoferstraße 20, 82152 Planegg-Martinsried, GermanyInstitute of Musculoskeletal Medicine (IMM), Musculoskeletal University Center Munich (MUM), LMU Hospital, Fraunhoferstraße 20, 82152 Planegg-Martinsried, GermanyInstitute of Musculoskeletal Medicine (IMM), Musculoskeletal University Center Munich (MUM), LMU Hospital, Fraunhoferstraße 20, 82152 Planegg-Martinsried, GermanyDepartment of Orthopaedics and Trauma Surgery, Musculoskeletal University Center Munich (MUM), Ludwig-Maximilians-University (LMU) Hospital, Fraunhoferstraße 20, 82152 Planegg-Martinsried, GermanyUrologischen Klinik und Poliklinik, LMU Hospital, Marchioninistr 15, 81377 München, GermanyUrologischen Klinik und Poliklinik, LMU Hospital, Marchioninistr 15, 81377 München, GermanyDepartment of Orthopaedics and Trauma Surgery, Musculoskeletal University Center Munich (MUM), Ludwig-Maximilians-University (LMU) Hospital, Fraunhoferstraße 20, 82152 Planegg-Martinsried, GermanyDepartment of Orthopaedics and Trauma Surgery, Musculoskeletal University Center Munich (MUM), Ludwig-Maximilians-University (LMU) Hospital, Fraunhoferstraße 20, 82152 Planegg-Martinsried, GermanyProstate cancer bone metastasis is still one of the most fatal cancer diagnoses for men. Survival of the circulating prostate tumor cells and their adaptation strategy to survive in the bone niche is the key point to determining metastasis in early cancer stages. The promoter of <i>SFRP2</i> gene, encoding a WNT signaling modulator, is hypermethylated in many cancer types including prostate cancer. Moreover, SFRP2 can positively regulate osteogenic differentiation in vitro and in vivo. Here, we showed SFRP2 overexpression in the prostate cancer cell line PC3 induces an epithelial mesenchymal transition (EMT), increases the attachment, and modifies the transcriptome towards an osteoblast-like phenotype (osteomimicry) in a collagen 1-dependent manner. Our data reflect a novel molecular mechanism concerning how metastasizing prostate cancer cells might increase their chance to survive within bone tissue.https://www.mdpi.com/2073-4409/11/24/4081SFRP2osteomimicryprostate cancerPC3bone metastasisEMT
spellingShingle Elif Akova Ölken
Attila Aszodi
Hanna Taipaleenmäki
Hiroaki Saito
Veronika Schönitzer
Michael Chaloupka
Maria Apfelbeck
Wolfgang Böcker
Maximilian Michael Saller
SFRP2 Overexpression Induces an Osteoblast-like Phenotype in Prostate Cancer Cells
Cells
SFRP2
osteomimicry
prostate cancer
PC3
bone metastasis
EMT
title SFRP2 Overexpression Induces an Osteoblast-like Phenotype in Prostate Cancer Cells
title_full SFRP2 Overexpression Induces an Osteoblast-like Phenotype in Prostate Cancer Cells
title_fullStr SFRP2 Overexpression Induces an Osteoblast-like Phenotype in Prostate Cancer Cells
title_full_unstemmed SFRP2 Overexpression Induces an Osteoblast-like Phenotype in Prostate Cancer Cells
title_short SFRP2 Overexpression Induces an Osteoblast-like Phenotype in Prostate Cancer Cells
title_sort sfrp2 overexpression induces an osteoblast like phenotype in prostate cancer cells
topic SFRP2
osteomimicry
prostate cancer
PC3
bone metastasis
EMT
url https://www.mdpi.com/2073-4409/11/24/4081
work_keys_str_mv AT elifakovaolken sfrp2overexpressioninducesanosteoblastlikephenotypeinprostatecancercells
AT attilaaszodi sfrp2overexpressioninducesanosteoblastlikephenotypeinprostatecancercells
AT hannataipaleenmaki sfrp2overexpressioninducesanosteoblastlikephenotypeinprostatecancercells
AT hiroakisaito sfrp2overexpressioninducesanosteoblastlikephenotypeinprostatecancercells
AT veronikaschonitzer sfrp2overexpressioninducesanosteoblastlikephenotypeinprostatecancercells
AT michaelchaloupka sfrp2overexpressioninducesanosteoblastlikephenotypeinprostatecancercells
AT mariaapfelbeck sfrp2overexpressioninducesanosteoblastlikephenotypeinprostatecancercells
AT wolfgangbocker sfrp2overexpressioninducesanosteoblastlikephenotypeinprostatecancercells
AT maximilianmichaelsaller sfrp2overexpressioninducesanosteoblastlikephenotypeinprostatecancercells